Quality control measurement, library preparation and high — throughput sequencing for WGS, WES, WGBS, RNA-seq and ChIP-seq and quality control and sequencing services for ATAC-seq and Hi-C
Quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS,~200 samples), Whole Exome Sequencing (WES,~ 50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immuno-precipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high – throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq,~40 samples) and Hi-C (16 samples) services. The study is part of ongoing Academy of Finland Center of Excellence in Tumor Genetics project led by Professor Lauri Aaltonen at the University of Helsinki. The project builds on existing data received from previous sequencing projects by Tumor Genomics laboratory which was produced using Illumina sequencing platform, and thus the sequencing data purchased from the service provider should be compatible with Illumina’s data type.
Määräaika
Tarjousten vastaanottamisen määräaika oli 2018-07-26.
Hankinta julkaistiin 2018-06-26.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
hankintailmoitus (2018-06-26) Kohde Hankinnan laajuus
Otsikko: Lääketieteellisten laboratorioiden palvelut
Lyhyt kuvaus:
Quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS,~200 samples), Whole Exome Sequencing (WES,~ 50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immuno-precipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high – throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq,~40 samples) and Hi-C (16 samples) services. The study is part of ongoing Academy of Finland Center of Excellence in Tumor Genetics project led by Professor Lauri Aaltonen at the University of Helsinki. The project builds on existing data received from previous sequencing projects by Tumor Genomics laboratory which was produced using Illumina sequencing platform, and thus the sequencing data purchased from the service provider should be compatible with Illumina’s data type.
Quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS,~200 samples), Whole Exome Sequencing (WES,~ 50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immuno-precipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high – throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq,~40 samples) and Hi-C (16 samples) services. The study is part of ongoing Academy of Finland Center of Excellence in Tumor Genetics project led by Professor Lauri Aaltonen at the University of Helsinki. The project builds on existing data received from previous sequencing projects by Tumor Genomics laboratory which was produced using Illumina sequencing platform, and thus the sequencing data purchased from the service provider should be compatible with Illumina’s data type.
Ilmoituksen metatiedot
Alkukieli: englanti 🗣️
Asiakirjatyyppi: hankintailmoitus
Sopimuksen luonne: Palvelut
Asetus: Euroopan unioni ja WTO-maat
Yhteinen hankintanimikkeistö (CPV)
Koodi: Lääketieteellisten laboratorioiden palvelut📦 Suorituspaikka
NUTS-alue: Helsinki-Uusimaa🏙️
Menettely
Menettelyn tyyppi: Avoin menettely
Tarjouksen tyyppi: Tarjous koskee kaikkia eriä
Myöntämisperusteet
Kokonaistaloudellisesti edullisin tarjous
Kohde Hankinnan laajuus
Arvioitu kokonaisarvo: 750 000 EUR 💰
Lyhyt kuvaus:
Quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS,~200 samples), Whole Exome Sequencing (WES,~ 50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immuno-precipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high – throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq,~40 samples) and Hi-C (16 samples) services.
Quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS,~200 samples), Whole Exome Sequencing (WES,~ 50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immuno-precipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high – throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq,~40 samples) and Hi-C (16 samples) services.
Kesto: 24 kuukautta
Menettely
Tarjousten vastaanottoaika: 14:00
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
suomi 🗣️
Tarjouksen voimassaoloaika: 6 kuukautta
Tarjousten avauspäivä: 2018-07-26 📅
Tarjousten avausaika: 14:30
Hankintaviranomainen Tunnistetiedot
Kansallinen rekisterinumero: 0313471-7
Muu hankintaviranomaisen tyyppi: University
Yhteystiedot
Asiakirjojen URL-osoite: https://hanki.tarjouspalvelu.fi/hanki🌏
Ilmoitus tehdystä sopimuksesta (2019-02-01) Kohde Hankinnan laajuus
Lyhyt kuvaus:
Post notice quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS, ~200 samples), Whole Exome Sequencing (WES, ~50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immunoprecipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high — throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq, ~40 samples) and Hi-C (16 samples) services. The study is part of ongoing Academy of Finland Center of Excellence in Tumor Genetics project led by Professor Lauri Aaltonen at the University of Helsinki. The project builds on existing data received from previous sequencing projects by Tumor Genomics laboratory which was produced using Illumina sequencing platform, and thus the sequencing data purchased from the service provider should be compatible with Illumina’s data type.
Post notice quality control measurement, library preparation and high — throughput sequencing for Whole Genome Sequencing (WGS, ~200 samples), Whole Exome Sequencing (WES, ~50 samples), Whole Genome Bisulfite Sequencing (WGBS, ~100 samples), RNA sequencing (RNA-seq, ~200 samples) and Chromatin Immunoprecipitation Sequencing (ChIP-seq, ~500 samples) and quality control measurement and high — throughput sequencing for Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq, ~40 samples) and Hi-C (16 samples) services. The study is part of ongoing Academy of Finland Center of Excellence in Tumor Genetics project led by Professor Lauri Aaltonen at the University of Helsinki. The project builds on existing data received from previous sequencing projects by Tumor Genomics laboratory which was produced using Illumina sequencing platform, and thus the sequencing data purchased from the service provider should be compatible with Illumina’s data type.